by Ingredion

Mannitab Pharma Specialities achieves EXCiPACT certification

In April 2026, Mannitab Pharma Specialities Pvt. Ltd. was awarded the EXCiPACT GMP and GDP Certification by SGS, one of EXCiPACT’s internationally recognized certification bodies. This achievement underscores Mannitab’s commitment to quality and regulatory compliance in the manufacturing of pharmaceutical excipients. The EXCiPACT certification confirms that Mannitab complies with the EXCiPACT standards for: Spray‑dried Mannitol: […]

In April 2026, Mannitab Pharma Specialities Pvt. Ltd. was awarded the EXCiPACT GMP and GDP Certification by SGS, one of EXCiPACT’s internationally recognized certification bodies.

This achievement underscores Mannitab’s commitment to quality and regulatory compliance in the manufacturing of pharmaceutical excipients.

The EXCiPACT certification confirms that Mannitab complies with the EXCiPACT standards for:

“This EXCiPACT certification reflects our robust compliance with international GMP and GDP requirements for pharmaceutical excipients and marks a significant milestone for the Mannitab site,” explains Bhoomi Alakh Bhatt, Senior Pharma QMS Specialist at Ingredion.

“Achieving EXCiPACT certification reinforces our ongoing commitment to quality, regulatory excellence, and customer confidence,” adds Pushpavalli Krishnamurthy, Senior Manager – Pharma, Beauty & Home Regulatory & QMS at Ingredion.

Mannitab Pharma Specialities Private Limited is a joint venture between Ingredion and M.B. Sugars.